GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Revenio Group Oyj (OTCPK:REVXF) » Definitions » EV-to-Revenue

Revenio Group Oyj (Revenio Group Oyj) EV-to-Revenue : 7.25 (As of May. 12, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Revenio Group Oyj EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Revenio Group Oyj's enterprise value is $761.9 Mil. Revenio Group Oyj's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $105.1 Mil. Therefore, Revenio Group Oyj's EV-to-Revenue for today is 7.25.

The historical rank and industry rank for Revenio Group Oyj's EV-to-Revenue or its related term are showing as below:

REVXF' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.46   Med: 10.69   Max: 26.39
Current: 7.28

During the past 13 years, the highest EV-to-Revenue of Revenio Group Oyj was 26.39. The lowest was 2.46. And the median was 10.69.

REVXF's EV-to-Revenue is ranked worse than
75.18% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: 3.265 vs REVXF: 7.28

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-12), Revenio Group Oyj's stock price is $28.35. Revenio Group Oyj's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $3.96. Therefore, Revenio Group Oyj's PS Ratio for today is 7.16.


Revenio Group Oyj EV-to-Revenue Historical Data

The historical data trend for Revenio Group Oyj's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revenio Group Oyj EV-to-Revenue Chart

Revenio Group Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.10 21.82 18.72 10.46 7.45

Revenio Group Oyj Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.99 8.47 5.52 7.45 6.78

Competitive Comparison of Revenio Group Oyj's EV-to-Revenue

For the Medical Devices subindustry, Revenio Group Oyj's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revenio Group Oyj's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Revenio Group Oyj's EV-to-Revenue falls into.



Revenio Group Oyj EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Revenio Group Oyj's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=761.859/105.108
=7.25

Revenio Group Oyj's current Enterprise Value is $761.9 Mil.
Revenio Group Oyj's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $105.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Revenio Group Oyj  (OTCPK:REVXF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Revenio Group Oyj's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=28.35/3.959
=7.16

Revenio Group Oyj's share price for today is $28.35.
Revenio Group Oyj's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.96.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Revenio Group Oyj EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Revenio Group Oyj's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Revenio Group Oyj (Revenio Group Oyj) Business Description

Traded in Other Exchanges
Address
Ayritie 22, Vantaa, FIN, 01510
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective and easy-to-use health tech-related screening devices for the detection of diseases of significance to public health. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. Its eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company's geographical segments include Finland, Other Europe, and Others.

Revenio Group Oyj (Revenio Group Oyj) Headlines

From GuruFocus

Q4 2023 Revenio Group Oyj Earnings Call Transcript

By GuruFocus Research 02-28-2024